I agree that the fact of disclosure is very, very encouraging. It's almost as if the average investor might be able to make an informed decision, what a switch <g>.
I'd actually freed up some cash yesterday, before the NR, with an eye toward getting back in. The news that Pennsaid won't be in the US for three years, though, is quite major IMO. Unless the lack of growth in Canada is somehow reversed, we're not looking at cash-flow positive operation for some time. I may believe in the products, and in the potential of WF10, but just at the moment I don't see ROI in the next three years. Oh, down the road a bit, sure, if they can raise money to prove up WF10, and once it seems clear that the FDA reservations on Pennsaid can be overcome, somebody could take DMX out, and probably at a very nice premium over today's 60 cents. But in the next year? Two years?
Don't get me wrong -- I'm emphatically onside with the idea that things are better today than they were a month ago. Just not enough better to get me off the sidelines just yet. And to all those who are braver than I, sincere good wishes.
FWIW |
